It is concluded that EAM-2201 has the likely to induce in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and it is evaluated in pooled human liver microsomes. The strategy as well as the parameterization is examined for a number of floor and bulk issues. Especially we existing calculatio